Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Frank van Aarle"'
Autor:
Rik de Greef, Marita Prohn, Christine McCrary Sisk, Frank van Aarle, Anthe S. Zandvliet, Barbara J. Stegmann
Publikováno v:
British Journal of Clinical Pharmacology. 82:74-82
Aim The aim of the present study was to characterize the pharmacokinetic profile of corifollitropin alfa and examine the relationships between dose, intrinsic factors [body weight, body mass index (BMI), age and race] and corifollitropin alfa pharmac
Autor:
Diana Montgomery, Anish Mehta, Elisabeth Riedl, Christine Bangert, Ann Horowitz, Frank van Aarle, Tamara Kopp, Xiaoli Shirley Hou, Elli K. Greisenegger, Sauzanne Khalilieh, Thomas Marbury, Wendy M. Blumenschein, Anthe S. Zandvliet, Edward P. Bowman, Claus Zachariae, Danlin Xu, Harald Kittler, Terrill K. McClanahan
Publikováno v:
Nature. 521:222-226
A proof-of-concept phase I clinical trial demonstrates that targeting interleukin (IL)-23 with an antibody that binds to the p19 subunit leads to clinical improvement of disease in patients with moderate to severe psoriasis. Sauzanne Khalilieh and co
Autor:
Anish Mehta, Tamara Kopp, Elisabeth Riedl, Christine Bangert, Edward Bowman, Elli Greisenegger, Ann Horowitz, Harald Kittler, Wendy Blumenschein, Terrill McClanahan, Thomas Marbury, Claus Zachariae, Danlin Xu, Xiaoli (Shirley) Hou, Anthe Zandvliet, Diana Montgomery, Frank van Aarle, Sauzanne Khalilieh
Publikováno v:
Protocol Exchange.
Autor:
Rik de Greef, Tomoko Freshwater, Anna Georgieva Kondic, Eric Mangin, Marianne van Vugt, Frank van Aarle
Publikováno v:
Journal of Clinical Oncology. 34:3063-3063
3063Background: Monoclonal antibodies (mAb) can evoke immunogenicity, leading to production of antidrug antibodies (ADA). Pembro, a humanized mAb against PD-1, has demonstrated efficacy in NSCLC an...
Autor:
Francis, Paolucci, Helma, Frasa, Frank, Van Aarle, Anna, Capdevla, Marie-Christine, Clavies, Theo, van Dinther, François, Donat, Yvonne, Hendriks, Michiel, van den Heuvel, Teresa, Nadal, Fabrice, Lagrange, Joseph, Necciari, Yolanda, Perez
Publikováno v:
Clinical laboratory. 49(9-10)
Fondaparinux is a synthetic selective inhibitor of factor Xa recently approved for thromboprophylaxis after major orthopedic surgery. Determination of its concentration gives valuable insight into specific pharmacokinetics or safety studies. The aim
Publikováno v:
In Journal of the American Academy of Dermatology September 2018 79(3) Supplement 1:AB157-AB157
Autor:
Norman, Robert J., Zegers-Hochschild, Fernando, Salle, Bruno S., Elbers, Jolanda, Heijnen, Esther, Marintcheva-Petrova, Maya, Mannaerts, Bernadette, Trust Investigators
Publikováno v:
Human Reproduction; Aug2011, Vol. 26 Issue 8, p2200-2208, 9p, 1 Diagram, 6 Charts
Autor:
Jennifer Grayer Moore
Fashion design is increasingly gaining attention as an important form of cultural expression. However, scholarship has largely focused on specific designers and their finished products. This collection reveals the crucial foundational art and craft o